{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T15:05:22Z","timestamp":1784214322501,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.cardfail.2023.01.005","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T03:20:33Z","timestamp":1675740033000},"page":"719-729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Time to Triple Therapy in Patients With de Novo Heart Failure With Reduced Ejection Fraction: a Population-Based Study"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0346-3484","authenticated-orcid":false,"given":"NARIMAN","family":"Sepehrvand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MAJID","family":"NABIPOOR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ERIK","family":"YOUNGSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FINLAY A.","family":"MCALISTER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2724-4086","authenticated-orcid":false,"given":"JUSTIN A.","family":"EZEKOWITZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2023.01.005_bib0001","doi-asserted-by":"crossref","first-page":"E365","DOI":"10.9778\/cmajo.20150130","article-title":"The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis","volume":"4","author":"Tran","year":"2016","journal-title":"CMAJ Open"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0002","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"Maddox","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0003","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0004","first-page":"531","article-title":"CCS\/CHFS Heart Failure Guidelines Update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction","volume":"37","author":"McDonald","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0005","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/jama.2009.1493","article-title":"Use of aldosterone antagonists in heart failure","volume":"302","author":"Albert","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0006","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1751-7133.2011.00263.x","article-title":"Adherence to evidence-based guidelines for heart failure in physicians and their patients: lessons from the Heart Failure Adherence RetentionTrial (HART)","volume":"18","author":"Calvin","year":"2012","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0007","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.109.934471","article-title":"Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF)","volume":"122","author":"Fonarow","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0008","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0009","doi-asserted-by":"crossref","first-page":"253","DOI":"10.14503\/THIJ-12-2947","article-title":"Outpatient management of heart failure in the United States, 2006\u20132008","volume":"41","author":"Mosalpuria","year":"2014","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jchf.2014.04.012","article-title":"Triple therapy\" of heart failure with angiotensin-converting enzyme inhibitor, beta-blocker, and aldosterone antagonist may triple survival time: shouldn't we tell patients?","volume":"2","author":"Cole","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0011","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","volume":"396","author":"Vaduganathan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0012","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1007\/s12325-017-0618-4","article-title":"Pharmacotherapy choice is associated with 2-year mortality for patients with heart failure and reduced ejection fraction","volume":"34","author":"Albert","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0013","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.jacc.2019.03.464","article-title":"Reasons for lack of improvement in treatment with evidence-based therapies in heart failure","volume":"73","author":"Bozkurt","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106494","article-title":"Heart failure re-admission: measuring the ever shortening gap between repeat heart failure hospitalizations","volume":"9","author":"Bakal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/eurjhf\/hfq185","article-title":"Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics?","volume":"13","author":"Ezekowitz","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0016","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0017","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jchf.2014.11.010","article-title":"Assessing the use of international classification of diseases-10th revision codes from the emergency department for the identification of acute heart failure","volume":"3","author":"Frolova","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0018","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/00005650-200208000-00007","article-title":"Validity of information on comorbidity derived rom ICD-9-CCM administrative data","volume":"40","author":"Quan","year":"2002","journal-title":"Med Care"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0019","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1161\/HYPERTENSIONAHA.109.139279","article-title":"Validation of a case definition to define hypertension using administrative data","volume":"54","author":"Quan","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0021","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/1475-6773.00165","article-title":"Improved comorbidity adjustment for predicting mortality in Medicare populations","volume":"38","author":"Schneeweiss","year":"2003","journal-title":"Health Serv Res"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0022","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCHEARTFAILURE.113.000415","article-title":"Do outcomes for patients with heart failure vary by emergency department volume?","volume":"6","author":"Brar","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"986","key":"10.1016\/j.cardfail.2023.01.005_bib0023","first-page":"e1","article-title":"Factors associated with natriuretic peptide testing in patients presenting to emergency departments with suspected heart failure","volume":"32","author":"Sepehrvand","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0024","doi-asserted-by":"crossref","unstructured":"Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007;10:3\u201312. 10.1111\/j.1524-4733.2006.00139.x","DOI":"10.1111\/j.1524-4733.2006.00139.x"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0026","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"Yusuf","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0027","first-page":"561","article-title":"Treatment initiation patterns, modifications, and medication adherence among newly diagnosed heart failure patients: a retrospective claims database analysis","volume":"22","author":"Deschaseaux","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0028","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jamacardio.2020.0898","article-title":"Association of optimal implementation of sodium-glucose cotransporter 2 inhibitor therapy with outcome for patients with heart failure","volume":"5","author":"Bassi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2013.03.007","article-title":"Transitional adherence and persistence in the use of aldosterone antagonist therapy in patients with heart failure","volume":"165","author":"Curtis","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0030","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.cardfail.2021.03.012","article-title":"Sacubitril\/valsartan initiation and postdischarge adherence among patients hospitalized for heart failure","volume":"27","author":"Carnicelli","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0031","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCHEARTFAILURE.112.971119","article-title":"Changes in heart failure outcomes after a province-wide change in health service provision a natural experiment in Alberta","volume":"6","author":"McAlister","year":"2013","journal-title":"Canada. Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0032","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1503\/cmaj.1032017","article-title":"Impact of specialist follow-up in outpatients with congestive heart failure","volume":"172","author":"Ezekowitz","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2012.08.002","article-title":"Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications","volume":"164","author":"Atwater","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0034","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jchf.2020.04.019","article-title":"Care gaps in adherence to heart failure guidelines: clinical inertia or physiological limitations?","volume":"8","author":"Jarjour","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0035","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.jacc.2003.12.043","article-title":"From knowledge to practice in chronic cardiovascular disease: a long and winding road","volume":"43","author":"Majumdar","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0036","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ejhf.1645","article-title":"Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry","volume":"22","author":"Lain\u0161\u010dak","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0037","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/ejhf.1793","article-title":"Unravelling the interplay between hyperkalaemia, renin\u2013angiotensin\u2013 aldosterone inhibitor use and clinical outcomes: data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry","volume":"22","author":"Rossignol","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0038","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ejhf.2483","article-title":"Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata","volume":"24","author":"Stolfo","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0039","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/ejhf.1182","article-title":"Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry","volume":"20","author":"Savarese","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2018.06.011","article-title":"Initiation, continuation, switching, and withdrawal of heart failure medical therapies during hospitalization","volume":"7","author":"Bhagat","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0041","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1001\/jama.2020.21395","article-title":"Improving care for heart failure with reduced ejection fraction-a potential polypill-based strategy","volume":"324","author":"Agarwal","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0042","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.jacc.2022.03.338","article-title":"Electronic alerts to improve heart failure therapy in outpatient practice","volume":"79","author":"Ghazi","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2023.01.005_bib0043","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008538","article-title":"Disparity in the Setting of incident heart failure diagnosis","volume":"14","author":"Sandhu","year":"2021","journal-title":"Circ Heart Fail"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423000349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916423000349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:49:50Z","timestamp":1761029390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916423000349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1071916423000349"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2023.01.005","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time to Triple Therapy in Patients With de Novo Heart Failure With Reduced Ejection Fraction: a Population-Based Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2023.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}